Windtree Therapeutics, Inc. (WINT) Stock Exhibits Minor Volatility Despite Promising Istaroxime Developments
ST Staff
July 19, 2021
Windtree Therapeutics, Inc. (WINT) stock prices were down by 6.56% as of the market closing on July 16th2021, bringing the price per share down to